Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 8/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | CDK2 | P24941 | 1/20 | 0.44 |
| ▸ | HTR6 | P50406 | 2/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3951748 | 0.93 | ALDH1A1 (0.45) | CD274EPHX2ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL3942340 | 0.93 | ALDH1A1 (0.45) | CD274EPHX2ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL3943840 | 0.93 | ALDH1A1 (0.47) | CD274EPHX2ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL3941698 | 0.92 | ALDH1A1 (0.45) | CD274EPHX2ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL3946035 | 0.91 | L3MBTL1 (0.46) | CD274EPHX2ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL3941774 | 0.91 | CD274 (0.49) | CD274EPHX2ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL3942216 | 0.90 | ALDH1A1 (0.43) | CD274EPHX2ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL3949611 | 0.90 | ALDH1A1 (0.42) | CD274EPHX2ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL14307307 | 0.90 | ALDH1A1 (0.42) | CD274EPHX2ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL3950196 | 0.89 | ALDH1A1 (0.43) | CD274ALDH1A1CYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1802572-B1 | INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE | BAYER SCHERING PHARMA AG (DE) | 2009-04-22 | — | — | EP | claimed |
| US-20080004268-A1 | INHIBITORS OF SOLUBLE ADENYLATE CYCLASE | NGUYEN DUY | 2008-01-03 | — | — | US | disclosed |
| US-20080004268-A1 | INHIBITORS OF SOLUBLE ADENYLATE CYCLASE | NGUYEN DUY | 2008-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080004268-A1 | INHIBITORS OF SOLUBLE ADENYLATE CYCLASE | ADCY1, ADCY2, ADCY5 | CD274 4795/4885EPHX2 434/4885ALDH1A1 268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.